Overview

Accelerant Ethics advises organizations developing emerging biotechnologies and high-impact medical innovations on ethics, governance, and risk. We tailor engagements to each client’s stage, technology, and regulatory context.

Ethical risk assessment

• Systematic analysis of ethical, social, and governance risks tied to new technologies, products, or research programs.

• Deliverables: written memoranda, executive briefings, or internal review documents.

Governance design

• Design or refine oversight structures for novel or high-impact technologies, including:

  • Advisory boards

  • Review frameworks

  • Internal decision protocols

  • Risk assessment procedures

Executive and board advisory

• Confidential counsel for leadership and boards on ethically complex decisions, product rollout strategies, and emerging regulatory issues.

Research and regulatory strategy

• Guidance on human subjects research, consent design, compliance planning, and institutional oversight.

Public-facing ethics strategy

• Support to anticipate and respond to scrutiny from regulators, investors, partners, and the public.

Engagement model

• Work may be project-based or provided as an ongoing advisory relationship.

• Scope and deliverables are defined after an initial consultation.